Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
AbCellera Biologics Inc
About ABCL
AbCellera Biologics Inc. discovers and develops antibody medicines for indications across therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. Its platform integrates technology, data science, infrastructure, and interdisciplinary teams to solve the challenging antibody discovery problems. It is focused on advancing an internal pipeline of programs and collaborating on drug development programs with partners. Its first two internal programs, ABCL635 and ABCL575, are in late-preclinical studies. ABCL635 is an antibody drug candidate for metabolic and endocrine conditions, and ABCL575 is an antibody drug candidate with broad potential in inflammatory conditions and autoimmune diseases and an initial indication in atopic dermatitis. ABCL575 binds OX40L to disrupt OX40/OX40L signaling, a regulator of inflammatory pathways in AD. In addition to ABCL635 and ABCL575, it is advancing a pipeline of more than 20 internal discovery programs.
Find out what a historical investment in AbCellera Biologics Inc would be worth today using our ABCL stock calculator.
Market Capitalisation
$1.25B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
8.87M
High today
$4.28
Low today
$4.00
Open price
$4.26
52-week high
$6.52
52-week low
$1.94
Ready to start your investing journey with Stake?
Open an accountHow do I buy ABCL shares in Australia?
Buying ABCL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in AbCellera Biologics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ABCL
What is the ticker symbol of AbCellera Biologics Inc?
The ticker symbol for AbCellera Biologics Inc is ABCL.
How much is one share of ABCL?
One share of ABCL is valued at $4.12 as of 16 May 2026.
What is the market capitalisation of AbCellera Biologics Inc ABCL?
As of 16 May 2026 AbCellera Biologics Inc has a market cap of $1.25B.
What is the 52-week high for AbCellera Biologics Inc stock?
The AbCellera Biologics Inc 52-week high stock price is $6.52.
What is the 52-week low for AbCellera Biologics Inc stock?
The AbCellera Biologics Inc 52-week low stock price is $1.94.
Can I buy ABCL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ABCL shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ABCL on Stake
- Buy ABCL from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ABCL from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ABCL related stocks